Literature DB >> 33869098

A 29-year-old Bodybuilder with Liothyronine-induced Thyrotoxic Hypokalaemic Periodic Paralysis.

Querijn N E van Bokhorst1, Yvonne H M Krul-Poel1, Diederik L Smit2, Willem de Ronde3.   

Abstract

We describe a 29-year-old male bodybuilder with recurrent attacks of myalgia and muscle weakness associated with hypokalaemia and thyrotoxicosis due to abuse of liothyronine. The attacks quickly resolved after potassium supplementation and liothyronine cessation. We concluded that the patient had thyrotoxic hypokalaemic periodic paralysis (TPP). Although muscle weakness and hypokalaemia are prominent symptoms of TPP, underlying thyrotoxicosis may be overlooked. Up to 25% of androgen abusers also abuse thyroid hormone. Lack of recognition of thyroid hormone abuse as a cause of hypokalaemic periodic paralysis may result in unnecessary, potentially harmful medical investigations and improper treatment and advice. LEARNING POINTS: In patients with bouts of muscle weakness and hypokalaemia, thyrotoxic hypokalaemic periodic paralysis should be suspected and thyroid function should be evaluated.In bodybuilders and strength athletes, undisclosed abuse of performance and image-enhancing drugs, including thyroid hormone, should be suspected. © EFIM 2021.

Entities:  

Keywords:  Thyrotoxicosis; androgens; hypokalemic periodic paralysis; liothyronine

Year:  2021        PMID: 33869098      PMCID: PMC8046276          DOI: 10.12890/2021_002362

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

1.  Outpatient clinic for users of anabolic androgenic steroids: an overview.

Authors:  D L Smit; W de Ronde
Journal:  Neth J Med       Date:  2018-05       Impact factor: 1.422

Review 2.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

Review 3.  Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge.

Authors:  Annie W C Kung
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

4.  Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids.

Authors:  Diederik L Smit; Olivier de Hon; Bastiaan J Venhuis; Martin den Heijer; Willem de Ronde
Journal:  Scand J Med Sci Sports       Date:  2019-11-21       Impact factor: 4.221

5.  Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis.

Authors:  Devon P Ryan; Magnus R Dias da Silva; Tuck Wah Soong; Bertrand Fontaine; Matt R Donaldson; Annie W C Kung; Wallaya Jongjaroenprasert; Mui Cheng Liang; Daphne H C Khoo; Jin Seng Cheah; Su Chin Ho; Harold S Bernstein; Rui M B Maciel; Robert H Brown; Louis J Ptácek
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

  5 in total
  1 in total

Review 1.  Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge.

Authors:  Matti L Gild; Mark Stuart; Roderick J Clifton-Bligh; Audrey Kinahan; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.